A client taking nitrofurantoin for cystitis develops fever, flank pain, vomiting, and costovertebral-angle tenderness. Which action is appropriate?
1Continue the current agent because urine concentrations remain high, then reassess the fever after the course is completed.
2Hold the next dose, notify the prescriber, obtain cultures as ordered, and anticipate therapy with adequate renal-tissue penetration.✓ Correct answer
3Move the remaining doses to bedtime to reduce vomiting, then follow up when the cystitis course is complete.
4Add a magnesium-containing antacid with each dose to improve tolerance and continue the current regimen.
Explanation
The new systemic and flank findings suggest pyelonephritis. Nitrofurantoin is indicated for lower urinary infection, not pyelonephritis or perinephric abscess.
Quick answer Escalate upper-tract infection cues during nitrofurantoin therapy.
Why this is correct Continuing a lower-tract agent can delay effective treatment of a renal infection.
Easy analogy or mental picture Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.
Memory hook Drug, urgent cue, protective action, and reassessment endpoint.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.
Why the other choices are wrong Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.
References
1DailyMed: Nitrofurantoin CapsulesLower-tract indication and lack of pyelonephritis treatment
Medication-safety reviewVerify indication, current assessment, dose and route, organ function, interactions, urgent toxicity cues, authorized action, and measurable follow-up.